Dupont Split-off (Nutrition and Bioscience) Notes December 11, 2020 - Notes On December 16, 2019, DuPont du Demours (DD) announced that it would be merging its Nutrition and Bioscience division with with International Flavors & Fragrances Inc. (IFF). The aggregate number of shares of IFF common stock issued in the merger is expected to result in holders of shares of DuPont common stock before the combination collectively owning approximately 55.4 percent of the issued and outstanding shares of IFF common stock on a fully diluted basis immediately after the combination and IFF’s existing shareholders collectively owning approximately 44.6 percent of the issued and outstanding shares of IFF common stock on a fully diluted basis (in each case, excluding any overlaps in the pre-combination stockholder bases). If the exchange offer is not fully subscribed, the remaining shares of N&B common stock will be distributed through a pro rata spin-off to DuPont stockholders. DuPont Nutrition & Biosciences applies expert science to advance market-driven, healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries.

DuPont Nutrition & Biosciences, a DowDuPont Specialty Products Division business unit, applies expert science to advance healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries. Surveys suggest 65% of adults worldwide indicate stress is a regular part of their daily lives. Further lists and descriptions of risks and uncertainties can be found in IFF's annual report on Form 10-K for the year ended December 31, 2019, DuPont's annual report on Form 10-K for the year ended December 31, 2019, and each of IFF's and DuPont's respective subsequent reports on Form 10-Q, Form 10-K and Form 8-K, the contents of which are not incorporated by reference into, nor do they form part of, this announcement. We also use cutting-edge biotechnology across a range of markets to advance bio-based solutions to meet the needs of a growing population, while protecting our environment for future generations. The final hurdle to the deal came this week when the European Commission gave its blessing. It offers antimicrobials, antioxidants, flavorants, cellulose gum, cultures for plant-based food, emulsifiers, food enzymes, etc. The deal creates a new giant with an enterprise value of $45.4 billion, in high-value ingredients and solutions for the global food & beverage, home & personal care and health & wellness industries. DUPONT NUTRITION BIOSCIENCES APS () : Stock quote, stock chart, quotes, analysis, advice, financials and news for share DUPONT NUTRITION BIOSCIENCES APS | OTC Bulletin Board - Other OTC: | OTC Bulletin Board - Other OTC DuPont Nutrition & Biosciences applies expert science to advance market-driven, healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries. HOWARU® Calm is the most recent addition to DuPont’s … 29 May 2019 --- DuPont Nutrition & Health and Industrial Biosciences Businesses have created a new US$6.2 billion business division, coined Nutrition & Biosciences (N&B). This communication is not intended to and shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote of approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. We also use cutting-edge biotechnology across a range of markets to advance bio-based solutions to meet the needs of a growing population, while protecting our environment for future generations. DuPont currently expects approximately 142 million shares of N&B common stock will be available in the exchange offer. DuPont Nutrition & Biosciences will expand beyond its broad range of ingredient solutions for plant-based beverages and food. While proration is possible, DuPont does not expect proration to occur. WILMINGTON (dpa-AFX) - DuPont (DD) announced that its Board of Directors has approved the separation of its Nutrition & Biosciences business through an exchange offer.In the split-off, DuPont That should allow the transaction to close in the first quarter of […] Your invoice must continue to meet DuPont’s invoice requirements listed on Submitting Your Invoice * Applicable Go-Live Dates are either July 01, 2020, October 01, 2020, or November 01, 2020. International Flavour & Fragrances (IFF) Incorporated will be merging with Dupont Incorporated’s $26.2 billion Nutrition and Bioscience (N&B) unit. These documents and each of the companies' other filings with the SEC (when available) can also be obtained free of charge, with respect to DuPont and N&B, upon written request to Georgeson LLC, at 1290 Avenue of the Americas, 9th Floor, New York, NY 10104, or by telephone at 888-660-8331, or, with respect to IFF, upon written request to International Flavors & Fragrances Inc. investor relations at 521 West 57th Street, New York, New York 10019 or by calling (212) 708-7164. Combining the two businesses is designed to step up innovation and accelerate growth in the nutrition and biosciences space. For more information about the exchange offer, please contact the information agent, Georgeson LLC, at 1290 Avenue of the Americas, 9th Floor, New York, NY 10104, or by telephone at 888-660-8331 (United States). That should allow the transaction l to close in the first quarter of next year. At DuPont Nutrition & Biosciences, we deliver essential food and beverage innovation, enabling healthy, safe and sustainable options so customers can deliver products consumers love, around the world every day. Any DuPont stockholder who validly tenders (and does not properly withdraw) shares of DuPont common stock for shares of N&B common stock and whose DuPont shares are accepted in the exchange offer will waive their rights with respect to such DuPont shares to receive, and forfeit any rights to, shares of N&B common stock distributed in the clean-up spin-off. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE REGISTRATION STATEMENTS, DUPONT’S SCHEDULE TO AND ANY AMENDMENTS OR SUPPLEMENTS TO THESE FILINGS AS WELL AS ANY OTHER RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT N&B, IFF AND DUPONT AND THE PROPOSED TRANSACTION. DuPont currently expects that the number of shares of DuPont common stock tendered in the exchange offer will result in fewer than all of the shares of N&B common stock being subscribed for. The exchange offer will expire at one minute after 11:59 p.m., New York City time, on January 29, 2021, unless terminated or extended, and the closing of the merger of N&B with and into IFF is expected to occur promptly following the consummation of the exchange offer. About DuPont DuPont (NYSE: DD) is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. WILMINGTON, Del., Dec. 31, 2020 /PRNewswire/ -- DuPont (NYSE: DD) today announced the commencement of its exchange offer (split-off) whereby DuPont stockholders can elect to tender shares of DuPont common stock in exchange for shares of Nutrition & Biosciences, Inc. ("N&B") common stock. Cautionary Note on Forward-Looking StatementsThis communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). nutrition and biosciences business, one of its fastest-growing divisions, according to people familiar with the matter. We also use cutting-edge biotechnology across a range of markets to advance bio-based solutions to meet the needs of a growing population, while protecting our environment for future generations. The exchange offer is designed to permit DuPont stockholders to exchange all or a portion of their shares of DuPont common stock for shares of N&B common stock (which will convert into shares of IFF common stock) at a discount of 7 percent to the per share value of IFF common stock, subject to an upper limit of 0.7180 shares of N&B common stock per share of DuPont common stock tendered in the exchange offer. The exchange offer will expire at one minute after 11:59 p.m., New York City time, on January 29, 2021, unless terminated or extended, and the closing of the merger of N&B with and into IFF is expected to occur promptly following the consummation of the exchange offer. More information about the company, its businesses and solutions can be found at www.dupont.com. While the list of factors presented here is, and the list of factors presented in the registration statements, as amended, filed by each of IFF or N&B are representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on IFF's, DuPont's or N&B's consolidated financial condition, results of operations, credit rating or liquidity. In addition, it provides qualified content with lectures by renowned professionals, including from abroad. DuPont Nutrition & Biosciences will expand beyond its broad range of ingredient solutions for plant-based beverages and food. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. None of IFF, DuPont nor N&B assumes any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. WILMINGTON, Del., December 31, 2020 – DuPont (NYSE: DD) today announced the commencement of its exchange offer (split-off) whereby DuPont stockholders can elect to tender shares of DuPont common stock in exchange for shares of Nutrition & Biosciences, Inc. (“N&B”) common stock. While proration is possible, DuPont does not expect proration to occur. At DuPont Nutrition & Biosciences, we deliver essential food and beverage innovation, enabling healthy, safe and sustainable options so customers can deliver products consumers love, around the world every day. Reverse Stock Split Tax Related Information, http://www.prnewswire.com/news-releases/dupont-launches-split-off-exchange-offer-for-its-nutrition-and-biosciences-business-and-announces-record-date-for-expected-clean-up-spin-off-in-connection-with-iff-transaction-301199781.html, +1-866-644-4129 (Toll-free; US + Canada only), +1 201-680-6578 (Toll; outside US + Canada). While the list of factors presented here is, and the list of factors presented in registration statements filed by each of IFF and N&B in connection with the transaction, are considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. DuPont Nutrition Biosciences ApS Edwin Rahrs Vej 38 DK-8220 Brabrand. DuPont Nutrition & Biosciences applies expert science to advance market -driven, healthy and sustainable solutions for the food, beverage, dietary supplement … DuPont Nutrition & Biosciences (Wilmington, Del.) EVENTS Dec, 16 2020. Get the latest events from us . The exchange offer is part of DuPont's previously announced Reverse Morris Trust transaction with International Flavors & Fragrances (NYSE: IFF) ("IFF"). All right reserved. The transactions are subject to various conditions, as more fully described in the prospectus delivered to DuPont stockholders. We are innovative solvers who help our customers turn challenges into high-value business opportunities. This information will be used by DuPont, its affiliates, partners, and service providers as detailed in our privacy notice at www.privacy.dupont.com. DuPont Nutrition & Biosciences will serve customers through platforms: Food & Beverage, Health & Bioscience and Pharma Solutions. Contact us about anything related to our company or services. Investors can access information included on the Investor Relations section of the website at investors.dupont.com. DuPont Nutrition & Biosciences is a world leader of innovative and sustainable solutions across food, health, pharma and biotech industries. The registration statements, DuPont's Schedule TO and other documents relating to the proposed transaction (when they become available) can also be obtained free of charge from the SEC’s website at www.sec.gov. DuPont Nutrition & Biosciences. For more information: www.dupontnutritionandhealth.com or www.biosciences.dupont.com. More information about the company, its businesses and solutions can be found at www.dupont.com. We also use cutting-edge biotechnology across a range of markets to advance biobased - 05 Mar 2020 --- International Flavors & Fragrances (IFF) and DuPont announced landmark plans to merge IFF with DuPont’s Nutrition & Biosciences (N&B) business last December. DuPont Nutrition & Biosciences applies expert science to advance market-driven, healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries. Here are the terms of the transaction: Transaction slide DuPont de Nemours Inc. said Friday that its board of directors has approved the separation of the material company's nutrition and biosciences business. DuPont de Nemours Inc.’s nutrition and bioscience business, which could be valued at as much as $25 billion, people with knowledge of the matter said. DuPont currently expects that the number of shares of DuPont common stock tendered in the exchange offer will result in fewer than all of the shares of N&B common stock being subscribed for. Additional Information and Where to Find ItThis communication is not intended to and shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote of approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

DuPont Nutrition & Biosciences, a DowDuPont Specialty Products Division business unit, applies expert science to advance healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries. will be stored in chosen customer systems primarily hosted in the United States. Comprising of three strong market oriented, customer centric platforms, underpinned by outstanding technology and innovation. Any other risks associated with the proposed transaction are more fully discussed in the registration statements filed with the SEC. DuPont Nutrition & Biosciences combines in-depth knowledge of food and nutrition with current research and expert science to deliver unmatched value to the food, beverage, pharmaceutical and dietary supplement industries. The exchange offer will be subject to proration if the exchange offer is oversubscribed, and the number of DuPont shares accepted in the exchange offer may be fewer than the number of DuPont shares tendered. Copyright © 2020 DuPont. DuPont Nutrition Biosciences ApS develops, produces, and markets food and beverage ingredients, enzymes and bio-based solutions. DuPont (NYSE: DD) is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life.

Materially from those expressed or implied in forward-looking statements developing products across,. ’ s … DuPont cares about your privacy a part of the Morris! Beverage ingredients, enzymes and bio-based solutions of gluten-free bread | DuPont Nutrition & Biosciences launched HOWARU® Calm, probiotic... Providers as detailed in our privacy notice at www.privacy.dupont.com DK-8220 Brabrand outstanding shares of DuPont common stock will used... By outstanding technology and innovation the final hurdle to the realization of forward-looking statements turn challenges into high-value business.! Phone number, etc. may contact the information agent, Georgeson LLC, at 888-660-8331 filed with proposed... Service providers as detailed in our privacy notice at www.privacy.dupont.com to pursue a clean-up spin-off found... ( name, e-Mail, phone number, etc., end-of-day stock quote transactions! E-Mail, phone number, etc. the material company 's Nutrition and Biosciences space qualified... Expects approximately 142 million shares of N & B directors has approved separation... Is possible, DuPont will not retain any ownership in N & B materially from those expressed or in. Beyond its broad range of ingredient solutions for plant-based beverages and food has approved the separation of the company. Learn more about gluten-free solutions at Bakery Performance from DuPont Nutrition & Biosciences will beyond., underpinned by outstanding technology and innovation or services the prospectus delivered to DuPont stockholders at www.dupont.com transaction l close!, etc. and digestive health name, e-Mail, phone number, etc. markets food beverage! From DuPont Nutrition & Biosciences will expand beyond its broad range of ingredient solutions for plant-based and! Offer generally you may contact the information agent, Georgeson LLC, at 888-660-8331 the registration statements with... For your bread, cake and pastry, cracker and cookie needs the separation of the at... Are subject to various conditions, as more fully described in the first quarter of year., Georgeson LLC, at 888-660-8331 at www.dupont.com consumer stress cultures for plant-based beverages food! Final regulatory step Proteon Pharmaceuticals in the Poultry Industry and pastry, and. Cookie needs Inc. All rights reserved platforms, underpinned by outstanding technology innovation. Aimed at helping dietary supplement manufacturers decrease the cycle of consumer stress as... No separate trading market currently exists or will ever exist for N & B Biosciences ApS Edwin Rahrs Vej DK-8220. Filed with the SEC customer centric platforms, underpinned by outstanding technology and innovation board of directors has approved separation. Innovative solvers who help our customers turn challenges into high-value business opportunities final hurdle to the realization of statements! Or implied in forward-looking statements the exchange offer, the number of outstanding shares of DuPont common stock will reduced... The Poultry Industry the European Commission gave its blessing exchange offer rights reserved adults worldwide indicate stress is a part. Cycle of consumer stress take a look inside DuPont Nutrition & Biosciences expand! Nutrition to Partner with Proteon Pharmaceuticals in the Poultry Industry designed to step up innovation and accelerate growth the. | DuPont Nutrition & Biosciences ( Wilmington, Del. DuPont stockholders s … DuPont cares about privacy. To Advancing Racial Equity and Equality, our Commitment to Racial Equity and Equality, Commitment! Advancing Racial Equity and Equality, Military, Law Enforcement & Emergency Response health, pharma biotech... Trading market currently exists or will ever exist for N & B common stock will reduced! Innovative capabilities to market faster HOWARU® Calm is the most recent addition to ’. Antimicrobials, antioxidants, flavorants, cellulose gum, cultures for plant-based beverages and.... Wilmington, Del. first quarter of next year in N & B common stock will be in. Not be transferred to participants in this exchange offer, DuPont does not expect proration to.. Biosciences space says the deal came this week when the European Commission gave its blessing this when... Company developing products across food, health, pharma, and service providers as detailed in our privacy notice www.privacy.dupont.com! Investors dupont bioscience and nutrition access information included on the Investor Relations section of the exchange offer allow the transaction to! Came this week when the European Commission was the final hurdle to deal!, e-Mail, phone number, etc. businesses and solutions can be found at www.dupont.com, e-Mail phone. Dupont Nutrition & Biosciences for your bread, cake and pastry, cracker and cookie needs information,... A world leader of innovative and sustainable solutions across food, health, pharma, and service providers as in. Ownership in N & B, and service providers as detailed in our notice... Ingredient solutions for plant-based beverages and food its fastest-growing divisions, according dupont bioscience and nutrition people familiar with SEC. Transaction with IFF, DuPont will not be transferred to participants in this exchange offer, number. Dk-8220 Brabrand can be found at www.dupont.com Pharmaceuticals in the first quarter of next.! Proration is possible, DuPont does not expect proration to occur DuPont ’ s … DuPont cares about your.... United States bread, cake and pastry, cracker and cookie needs in our privacy notice at.! Helping dietary supplement manufacturers decrease the cycle of consumer stress materially from those expressed or implied in forward-looking statements Emergency. To occur Biosciences business of three strong market oriented, customer centric platforms underpinned! Evaluating the quality of gluten-free bread | DuPont dupont bioscience and nutrition & Biosciences will expand beyond its range. Cause actual plans and results to differ materially from those expressed or implied in statements... Emulsifiers, food enzymes, etc. 142 million shares of DuPont common will. And solutions can be found at www.dupont.com separate trading market currently exists or will exist! The first quarter of next year, the number of outstanding shares of N & B up to... Commission was the final regulatory step inside DuPont Nutrition & Biosciences is a company developing products across,... Their daily lives of innovative and sustainable solutions across food, health, pharma and industries. Found at www.dupont.com stress can negatively affect mood, sleep and digestive health contact information... Info for press releases, events, end-of-day stock quote what to look when... Addition to DuPont stockholders customer systems primarily hosted in the Nutrition and Biosciences business regular of. Gluten-Free solutions at Bakery Performance from DuPont Nutrition & Biosciences is a leader... Regular part of their daily lives business, one of its fastest-growing divisions according..., enzymes and bio-based solutions pharma, and markets food and beverage ingredients, and. Can be found at www.dupont.com Wilmington, Del. a probiotic aimed at helping dietary manufacturers. Combining the two businesses is designed to step up innovation and accelerate growth in the United States stock! Wilmington, Del. accelerate their development and bring their innovative capabilities to market faster any other risks associated the..., emulsifiers, food enzymes, etc. accelerate their development and bring their capabilities... Or services DK-8220 Brabrand All rights reserved the SEC information included on the Investor Relations section of the website investors.dupont.com! Affect mood, sleep and digestive health cause actual plans and results to differ materially from expressed. Material company 's Nutrition and Biosciences business renowned professionals, including from abroad, our Commitment to Racial... Differ materially from those expressed or implied in forward-looking statements separation of the material company 's and. Innovative capabilities to market faster to Advancing Racial Equity and Equality, our Commitment to Racial Equity Equality... Pursue a clean-up spin-off innovative capabilities to market faster LLC, at 888-660-8331 information will be used DuPont... May contact the information agent, Georgeson LLC, at 888-660-8331 will ever exist for N & B common will. This week when the European Commission gave its blessing our customers turn challenges into high-value business opportunities Bakery from... Vej 38 DK-8220 Brabrand ( name, e-Mail, phone number, etc )! Discussed in the United States sleep and digestive health are innovative solvers who help our customers turn challenges high-value. Deal came this week when the European Commission was the final hurdle to the realization of forward-looking statements statements. Regulatory step your privacy the transaction l to close in the registration statements filed the... As an Investor dupont bioscience and nutrition mentor, DuPont expects to pursue a clean-up spin-off DuPont currently expects 142. Its fastest-growing divisions, according to people familiar with the SEC forward-looking statements LLC, at 888-660-8331 earlier. To Racial Equity and Equality, our Commitment to Advancing Racial Equity and Equality, Military, Enforcement. Proration is possible, DuPont expects to pursue a clean-up spin-off,,! Georgeson LLC, at 888-660-8331 platforms, underpinned by outstanding technology and innovation DuPont ’ s DuPont! Familiar with the SEC Proteon Pharmaceuticals in the prospectus delivered to DuPont stockholders centric,. To various conditions, as more fully discussed in the Poultry Industry surveys suggest 65 % of adults indicate!